Present and future of regenerative medicine. Liver Transplantation

Similar documents
Cellular repair of damaged organs. Repopulating scaffoldings in kidney and liver

BIOENGINEERING HUMAN LIVERS FOR TRANSPLANTATION: WHERE DO WE STAND NOW?

Transplantation Society. Transplantation Building Bridges to Excellence. World Wide Transplantation. Outline 9/28/2016

Bioengineered Livers: A New Tool for Drug Testing and a Promising Solution to Meet the Growing Demand for Donor Organs

Tissue Engineering: The art of growing body parts. Robby Bowles, Ph.D Cornell University

Looking Ahead: The Bio-Artificial Kidney

Artificial blood vessels

New Opportunities Through Innovations Jacques Pirenne, Transplant Surgeon, Leuven

New Opportunities Through Innovations Jacques Pirenne, Transplant Surgeon, Leuven Organ Shortage

Regenerative medicine technologies for therapy and modeling

Whole Organ Bioengineering Science & Sensibility. Doris A. Taylor, PhD, FAHA, FACC Director, Regenerative Medicine Research Texas Heart Institute

Promising Future for Ex vivo Tissue Fabrication. Eiji Kobayashi, MD, PhD Department of Organ Fabrication, Keio University School of Medicine, Japan

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

Regenerative Strategies for Vascular and Lung Tissues. Laura E Niklason MD, PhD

Stem cells and tissue engineering

Chronic liver diseases affect more than 500 million

Tissue Engineering for Blood Vessels

Layer-by-layer hepariniza on of decellularized liver matrices to reduce thrombogenicity of ssue engineered gra s

In Vitro Assembly of 3D Bile Duct Networks within Decellularized Extracellular Matrix Hydrogels

Supplementary Materials for

T e c h n i c a l R e p o r t s

Organ Fabrication - Future for Medicine -

Break the 3D barrier CORNING 3D CELL CULTURE

Stem Cell Research From Bench to Bedside

Within the past 2 decades, most of the major

Use of Decellularized Porcine Liver for Engineering Humanized Liver Organ

R03 NIH Grant Proposal 3-Dimensional Scaffold-Tissue Construct Bioprinting

Nanosystems in regenerative medicine. Jöns Hilborn Materials Chemistry The Ångström Laboratory Uppsala University Sweden

Methods in Bioengineering: 3D Tissue Engineering

Optimized protocol for whole organ decellularization

TISSUE ENGINEERING AND REGENERATION: TECHNOLOGIES AND GLOBAL MARKETS

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013

3D Cell Culture Product Intro. Bio-Byblos Biomedical

CHALLENGES OF 3D BIOPRINTING IN CLINICAL PRACTICE

BIOFUNCTIONALIZING PLANTS: USING NATURE AS TISSUE ENGINEERING SCAFFOLDS

Preparation of a three-dimensional extracellular matrix by decellularization of rabbit livers

Future implications of regenerative medicine on assisted reproductive technology. Regenerative medicine. History of Regenerative medicine

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

In Vitro Organogenesis of the Liver: Current Progress and Future Applications

Bioreactors in tissue engineering

cardiovascular cell Solutions

practice, few studies are available that clearly demonstrate the clinical benefit of 3D-printed materials(youssef et al., 2015).

A NANOFIBROUS HYDROGEL FOR BONE TISSUE ENGINEERING

The Electrospinning Company

2d, 3d, shear" Arti Ahluwalia University of Pisa

Engineering, Columbia University, New York, NY, USA; 3 Departments of Biomedical Engineering and Medicine, Columbia University, New York, NY USA

Lyset BOOST YOUR CELL CULTURE TODAY FOR THE EXPERIMENTS OF TOMORROW

Developing a human chip based platform for repeated dose toxicity testing. Heike Walles Roland Lauster Gerd Lindner Uwe Marx

Tissue Engineered Medical Products

HIGH-THROUGHPUT HUMAN TISSUE AND DISEASE MODELS. Organ on a chip. Now.

9/29/2016. Implantable Artificial Kidney: From Silicon Chips to Renal Clearance. ESRD Statistics. Arrhythmia Care as a Paradigm

Tissue Engineering and Regenerative Medicine

Microtechnology Tools for Studying the Cellular Environment

Sterilization Techniques Influence Physical Properties and Cell-Biomaterial Interactions in Plasticized Polylactide Foam Scaffolds

Des cellules-souches dans le poumon : pourquoi faire?

Cell Micropatterning Using Magnetite Nanoparticles and Magnetic Force

Bioprinting at the Naval Research Laboratory. Bradley Ringeisen, Ph.D. Head, Bioenergy and Biofabrication Section Chemistry Division

Your Power for Health. Magnetic cell culturing. The n3d approach

Regenerative Medicine and Stem Cell Therapies

Subject Index. Antithrombotic drugs See Drugs, antithrombotic

Regenerative strategies for kidney engineering

PRINCIPLES AND PRACTICE OF TISSUE ENGNEERING:

About Life Technologies Corporation

Design and Discovery of Resorbable Polymers for Coronary Stents

FABRICATION OF VASCULARIZED RENAL CONSTRUCTS JENNIFER HULING. A Dissertation Submitted to the Graduate Faculty of

10:10-10:22. YIA-1 A study of newly established human peripheral blood monocyte-derived ips cell line used in allergy research 10:22-10:32

Challenge 23: Retinal 3D

InVivo Therapeutics. Developing Innovative Products for Spinal Cord Injury

The Biomechanics of ProLayer Acellular Dermal Matrix: suture retention strength

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy

Affinity. A Paradigm Shift in Skeletal Reconstruction

Nature Medicine: doi: /nm.4169

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE

Cross-Linker Modulation to Maintain Phenotype of RGD-Alginate-Embedded Mesenchymal Stem Cells

EMA s role & responsibility for the development of modern/advanced therapies

Production and commercialisation of vascularized and customized bone Clinical trials, market authorisation Pre-clinical trials

Chapter 8. Comparison of static vs dynamic culture

Lecture 6: Programmed/Pulsed Drug Delivery and Drug Delivery in Tissue Engineering

What is the future of ACL reconstruction?

Growth factor delivery

Product Datasheet. CD31/PECAM-1 Antibody (C31.7) NBP mg. Unit Size: 0.1 mg. Store at 4C. Publications: 1

Seevix s SVXgro: A Spidersilk Scaffold for Tissue Engineering

Thirupathi Kumara Raja. S, 1 Thiruselvi. T, 1 Asit Baran Mandal, 1 Gnanamani. A, 1* Adyar, Chennai Tamil Nadu, India

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003

This document is downloaded from DR-NTU, Nanyang Technological University Library, Singapore.

Medicyte GmbH. Infinity Gets Cultured. European Business Development Conference, Dresden October 2014 Björn F. Lindemann, CEO

SIRRIS. Bioprinting: markets and opportunities. Grégory Nolens. QED AM in Medical November 4th 2014

ABSTRACT. Title of Document: ENGINEERING BIODEGRADABLE VASCULAR SCAFFOLDS FOR CONGENITAL HEART DISEASE

Biocompatibility and War and Peace

Decellularized Scaffolds: Concepts, Methodologies, and Applications in Cardiac Tissue Engineering and Whole-Organ Regeneration

University of Florida College of Engineering EDGE Course EMA 6590/6938: Advances in Biomaterials and Tissue Engineering for Healthcare

THE ROLE OF BIOMECHANICS IN LIVER TISSUE ENGINEERING

Laryngeal Bioreactor Mid-semester Presentation

CELLCOAT Protein Coated Cell Culture Vessels

What is a scaffold? A 3D structure which supports 3D tissue growth

BONE Tissue Scaffolds ( Degradable ) Prof. Yongnian Yan

BNG 331 Cell-Tissue Material Interactions. Wound Healing I

SUPPLEMENTARY INFORMATION

EX VIVO BIOENGINEERING OF LUNG

Development of a Hepatocyte Spheroid Culture Model for Drug Uptake, Metabolism and Transporter Studies

Transcription:

Present and future of regenerative medicine Liver Transplantation Mireia Caralt, MD PhD Servei Cirurgia HBP i Trasplantaments March 19, 2015

Introduction Strategies to increase the number of organs EXPAND DONATION CRITERIA - DCD donors - LIVING DONOR ORGAN AND TISSUE REGENERATION SPLIT

Introduction Solid organs: structural complexity!! Traquea Urine Bladder

Introduction Ideal scaffold : biocompatibility, biodegradability, porosity, structural support Artificial Scaffold Natural Scaffold Organ Extracellular Matrix - Difficult control of size, microarchitecture and interconnectivity of pores - Physical, chemical and molecular stimuli that enable cell engraftment - Preservation of vascular network - Low inmunogenicity

Introduction Decellularization Transplantation Recellularization Maturation

Introduction Caralt M. Organogenesis 2014;10(2):250

Decellularization Decellularization Transplantation Recellularization Maturation

Decellularization Different decellularization recipes in liver Uygun rat SDS Triton X-100 0.01% 24h, 0.1% 24h, 1% 24h 1% 30min 1ml/min Baptista rat Triton X-100 + NH4 OH 1%+3%, 3h 5ml/min Soto rat Trypsin + EGTA Triton X-100 + EGTA 0.02%+0.05%, 2h 3%+0.05%, 24h 8ml/min Bao rat Adenosine SDS 10mM 1% 4h, 0.5% 4h, 0.25% 4h 25ml/min Yagi pig SDS Triton X-100 0.01% 24h, 0.1% 24h, 1% 48h 1% 30min 30ml/min Ko pig Triton X-100 + NH4 OH 1%+3%, 3h 0.5ml/min

Decellularization Different decellularization recipes in liver Uygun rat SDS Triton X-100 Baptista rat Triton X-100 + NH4 OH Soto rat Trypsin + EGTA Triton X-100 + EGTA Bao rat Adenosine SDS Yagi pig SDS Triton X-100 Ko pig Triton X-100 + NH4 OH

Decellularization best decellularization protocol in kidneys Caralt et al. Am J Transplant 2015; 15:64-75

Decellularization Caralt et al. Am J Transplant 2015; 15:64-75

Recellularization Decellularization Transplantation Recellularization Maturation

Recellularization Primary rat hepatocytes hflcs + huvec

Recellularization Uygun. Nature 2010;16(7):814-821

Recellularization 20% albumin production of in vivo levels 30% drug metabolism gene expression of in vivo levels Uygun. Nature 2010;16(7):814-821

Recellularization hflc huvec p450 CYP2A (green) and p450 CYP3A (red) CK 19 (red) and albumin (green) Von Willebrand (red) and endothelial oxid nitric sinthetase (pink) Baptista et al. Hepatology 2010 Nov;12:604-617

Recellularization Direct parenchymal injection Continuous perfusion Multistep infusion Direct injections into different lobes Cells suspendended in culture media Cells through Porta Vein 4 steps at 10-15min interval Soto A. Tissue Eng Part C Methods 2011;17(6):677-86

Recellularization Soto A. Tissue Eng Part C Methods 2011;17(6):677-86

Background Decellularization Transplantation Recellularization Maturation

Transplantation * * ** * * ** * Baptista et al. Hepatology 2010;12:604-617 ** Uygun. Nature 2010;16(7):814-821 8h viability thrombosis

Transplantation LbL self-assembly technique Polyelectrolyte polydiallydimethylammoniuum chloride (PDADMAC) positively charged Heparine negatively charged Thromboresistant after 3h of blood perfusion After 72h, hepatocytes maintained normal morphology Bao et al. Cell Transplantation 2011;20:753-766

Transplantation Antibody conjugation method 1. Anti endothelial cell antibodies to stabilize seeded cells on the vessel walls. Rat anti-mouse CD31 antibody was conjuated to the acellular liver scaffold Ko et al. Biomaterials 2015;40:72-79

Transplantation Antibody conjugation method 1. Anti endothelial cell antibodies to stabilize seeded cells on the vessel walls: Rat anti-mouse CD31 antibody was conjuated to the acellular liver scaffold 2. ReEndothelization with endothelial cells (MS1) expressing GFP protein Ko et al. Biomaterials 2015;40:72-79

Transplantation Re-endothelialization characterization Ko et al. Biomaterials 2015;40:72-79

Transplantation Antibody conjugation method 1. Anti endothelial cell antibodies to stabilize seeded cells on the vessel walls: Rat anti-mouse CD31 antibody was conjuated to the acellular liver scaffold 2. ReEndothelization with endothelial cells (MS1) expressing GFP protein 3. Implantation of engineered porcine liver construct Heterotopically implantation into pig Left renal artery Portal vein Left renal vein - Inferior vena cava Ko et al. Biomaterials 2015;40:72-79

Transplantation In vivo functional testing Intraoperative 4h after implantation Ko et al. Biomaterials 2015;40:72-79

Transplantation In vivo functional testing: POD 1 Ko et al. Biomaterials 2015;40:72-79

Transplantation In vivo functional testing: POD 1 Ko et al. Biomaterials 2015;40:72-79

Transplantation In vitro functional testing: POD 1 Ko et al. Biomaterials 2015;40:72-79

Main concerns 70M human fetal hepatocytes 4 livers (17-21 weeks gestation) Baptista et al. Hepatology 2010 Nov;12:604-617 Number is important

size is important too Main concerns

Co-Culture with other non-parenchymal cells Future directions

Future directions Co-Culture with other non-parenchymal cells Cholangiocytes - Biliary tree

Summary Decellularized livers are a good option to obtain scaffolds because architecture and vasculature are well preserved Cells are happy in the scaffolds mature hepatocytes: viable and functional immature cells: differentiate into cells present in the liver Multistep recellularization Endothelization needed for transplantation Main concerns: number of cells and size of organoid Future directions: Coculture with other non-parenchymal cells Cholangiocytes and Bile Duct

Organ Bioprinting

Organ Bioprinting Organ Bioprinting: technology to fabricate scaffolds Based on the Additive Manufacturing Technology Technique that produces complex 3D structures being able to control the size, shape, distribution and interconnectivity of pores of the scaffold Allow direct cell deposition in organotypic architecture Mironov. Biomaterials 2009;30(12):2164-2174

Organ Bioprinting Mironov. Biomaterials 2009;30(12):2164-2174

Organ Bioprinting Mironov. Biomaterials 2009;30(12):2164-2174

Organ Bioprinting Seol et al. Eur J Cardiothorac Surg 2014;46:342-348

Organ Bioprinting Seol et al. Eur J Cardiothorac Surg 2014;46:342-348

Organ Bioprinting Seol et al. Eur J Cardiothorac Surg 2014;46:342-348